BioCentury
ARTICLE | Clinical News

Lambda lanthanum: Phase II data; Phase III

January 11, 1999 8:00 AM UTC

Sub-group results from an ongoing Phase II trial in the U.K. showed that 26 out of 28 patients re-established control of blood phosphate levels and 21 of those patients had phosphate concentrations be...